跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Piodart - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Piodart
Approved
STANDARD
Piodart
Stallion Laboratories Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e694d7f10b281681
Company
Stallion Laboratories Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
e694d7f10b281681
Drug Approval Philippines Name
Piodart
Product Name
Piodart
Registration Number
DRP-2807-01
Brand Name
Piodart
Generic Name
Pioglitazone Hydrochloride
Dosage Form
Tablet
Dosage Strength
30 mg
Manufacturer
Stallion Laboratories Pvt. Ltd.
Importer
Ambica International Trading Corporation
Distributor
Ambicare International Corporation
Issuance Date
29 December 2023
Expiry Date
22 February 2029
Pharmacologic Category
Oral Hypoglycemic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e694d7f10b281681
Type
Standard
Back to Philippines FDA Approvals